We are happy to highlight a cross-section of Emergence clients, below:
AbCelex Technologies is a biotechnology company focused on developing leading-edge innovations and capabilities to address some of the world’s major food animal health and food safety challenges. The company is committed to the discovery, development and commercialization of innovative solutions to advance the health of food animals and human food safety. AbCelex uses an antibody-based approach to control pathogens in farm animals related to food-borne illnesses.
Advanced Extraction Systems Inc. (AESI) designs, engineers and fabricates manual and fully automated supercritical fluid botanical CO2 extraction systems for the medical marijuana and hemp industries in North America. AESI has assembled a skilled management team and world class scientific advisory group with over 60 years of experience in supercritical fluid design and processes. The company has an exclusive manufacturing agreement with Diversified Metal Engineering Ltd. (DME), an innovative engineering and manufacturing company located in Prince Edward Island, Canada, with over 25 years of manufacturing experience to build the systems in their state of the art CRN, ASME and ISO accredited facility.
Aim.OA is a new, cloud-based electronic decision making tool for managing canine arthritis. This new revolutionary system enables veterinary practices to create effective, individualized multimodal plans for each patient. The new digitised process is based on the Aim-OA system, which has been developed and used in arthritis management for over 15 years by some of the world’s leading authorities in canine arthritis. The system also records interventions and monitors outputs.
Animal Ethics Pty. Ltd. is a research and development company specializing in the development of wound care and pain relief products for humans, livestock, and companion animals. Animal Ethics was the first company, globally, to have a topical pain relief product registered for use on farm animals. Their vision is that highly effective, safe, affordable and practical pain relief products are developed and made widely available to prevent pain and minimize suffering associated with surgical husbandry procedures and traumatic wounds in humans, livestock and companion animals.
BioSpa (Quann) Cosmeceuticals Inc. focuses on the development, manufacture and marketing of a premium professorial skincare line: Quannessence Skincare. Full commercialization began in 2013 and BioSpa has grown steadily with a strong presence throughout the Maritimes and Newfoundland. The Quannessence brand is gaining traction in other parts of Canada and is becoming recognized as a leading brand in its sector. The Quannessence line was developed to address a gap in the provision of effective treatments of problematic skin conditions for estheticians and professional skincare providers. Products are available for sale to the public only through professionals.
Canada’s Island Garden Inc. operates within a new and highly regulated system under the terms of the Access to Cannabis for Medicinal Purposes Regulations (ACMPR). As a horticultural business, it also stands on the shoulders of generations of farming Jewells and the culture of Prince Edward Island. We know the origin, quality and potency of medical marijuana is important. To that end, CIG makes this promise: our horticultural experience, pristine environment, and stringent quality controls will result in a consistent and high quality product at a reasonable price. All delivered with exceptional Prince Edward Island customer service!
Last year in the U.S, over 700,000 people got infections from visiting a hospital. We threw out $109B worth of rotten food and beverages, and over 200,000 bottles of cosmetics spoiled. These are just a few statistics on the worldwide war against bad microorganisms. Each year people get sick, food rots on shelves and any product susceptible to spoilage undoubtedly spoils. Each industry faces the common problem of microbes, but with different microorganisms to combat. However, the traditional “one size fits all” antimicrobial agents are becoming less and less effective and industries are looking for personalized antimicrobial solutions. At the same time, industries are under intense pressure from the public to use less chemical sounding preservatives in products. Something about drinking sodium benzoate just does not sound attractive! Chinova Bioworks is developing this solution, using a unique biopolymer called Chitosan. The key benefit of this platform technology is that we can personalize a highly effective, safe, label-friendly and natural antimicrobial to address the needs of each industry’s individual microbial issues. Starting in the beverage space, we hope to make advancements that will allow us to grow into the higher-end markets like cosmetics, medical and pharmaceutical industries.
Dalriada Therapeutics Inc. is a start-up focusing on the development of novel small molecules for a range of therapeutic and diagnostic applications. With broad expertise in drug discovery and chemosensor technologies, the company’s efforts are currently centred on the preclinical development of a novel class (DT1) of small molecule inhibitors in cancers of the blood and brain as well as proliferative skin pathologies. Dalriada is engaged in the development of small molecule-based diagnostic technologies for Alzheimer’s disease and infections. In addition to these R&D activities, Dalriada offers services in medicinal chemistry and custom synthesis.
Delivra Corp. manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivRelief™ brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSport™ brand for sports performance. LivRelief™ products are available in pharmacies, grocery chains, and independent health food stores across Canada, and in the United States on-line. In parallel, Delivra also has a mandate to license its patent-pending proprietary transdermal delivery technology platform to pharmaceutical companies globally, for the transdermal delivery of repurposing Rx molecules to treat a broad range of conditions, along with licensing its over-the-counter products globally.
Fitorex is an innovative, R&D-orientated company devoted to the development and production of YASO®, specially sprouted soybean, as well as value-added functional food products based on YASO®. Fitorex has pioneered the world’s first high-yield, industrial-scaled sprouting process of soybean with unique patented composition. Its premium crackers, crisps, snacks and frozen products are not only nutritious, natural, and fit into a sustainable and healthier future, but also the highest quality ones on the market.
GenCanBio Inc. is a biotechnology company that has developed proprietary high-throughput and low-cost in vivo bioassays to screen plant compounds for a variety of indications. This allows GenCanBio to quickly and cheaply determine which compounds show bio-activity for specific indications and to take early steps to protect associated intellectual property.
Island Water Technologies (IWT) is a wastewater technology company specializing in modular, solar powered treatment solutions. IWT provides robust, low-complexity self-powered wastewater treatment for remote work camps, military operations, disaster relief and mining industries.
Liv9 Nutrition – Founded by pharmacists, Liv9 Nutrition is a New Brunswick-based life sciences company that designs, manufactures, and distributes high quality nutraceuticals that are backed by scientific research. With a focus on purity, quality, and service, Liv9 grew out of a desire to help consumers lead healthy lifestyles through targeted supplementation with unique formulations and processes.
Nature’s Crops International (NCI) is a manufacturer of specialty oils for dietary supplements, food and personal care products. All oils produced by NCI are from the highest quality crops, grown by growers who follow strict management protocols for sustainability and identity preservation. NCI ensures the crops produced are grown, processed, packaged, and delivered in a safe, sustainable, traceable, and cost-competitive manner – from soil to oil…naturally.
Neurodyn Life Sciences is a Canadian biotechnology company focused on identifying, validating and developing natural compounds into both prescription drugs and natural products for the early treatment of neurological diseases. Through its offices in Charlottetown, Halifax, and Germany, Neurodyn Life Sciences manages prescription drug and natural health product commercialization as well as subsidiaries in fine chemicals & medicinal chemistry and animal modeling of neurological disease.
NeuroQuest Inc. is a drug development company seeking new approaches to modulation of nerve transmission and promising clinical applications particularly for neuropathic pain. NeuroQuest focuses on a first-in-class small molecule drug discovery platform that is based on bioactives discovered in plant extracts showing efficacy for neuropathic pain. NeuroQuest has entered into a joint venture with Concept2clinic.com, a highly qualified pharmaceutical development team with expertise and lab facilities located in Toronto, Canada. Expertise exists in all aspects of drug development, from lead chemistry development to clinical research, regulatory affairs and commercialization. NeuroQuest is pursuing a dual-track of market entry for nerve pain products, pursuing a natural health product or OTC drug product in Canada, USA and Asia, and a prescription-status product for the US and other markets. These products promise to be fast-acting, safe, effective, non-numbing and non-burning, unlike current market offerings.
Noblegen Inc. is an advanced bioproducts manufacturer dedicated to developing cost-effective, naturally-derived biomaterials and biochemicals for a wide range of uses. We utilize a unique platform combining proven industrial methods with our proprietary “directed expression” technique to commercially cultivate microorganisms, allowing for development of cost-effective dietary, health and biochemical products. These products are inspired by a simple vision – to make a meaningful difference by delivering biological solutions for some of the world’s greatest problems, creating an avenue for a healthier, more balanced relationship between people and planet.
Prosper Animal Health is an animal health company that is creating and commercializing a portfolio of breakthrough vaccines for multiple livestock and companion animal species. Prosper Animal Health controls an internationally patented breakthrough technology that will improve the effectiveness, diversity, safety, and duration of vaccines.
Retrievium is a data-management and discovery platform for the chemical sciences. It allows users to share, search, and discover high-accuracy quantum data on chemical systems. Unlike traditional data management or molecular modeling tools, the platform harnesses a network of scholars, data, and machine-learning technology that allow users to discover new molecular structures for lead identification, and apply or develop high-accuracy predictive models quickly and easily.
RPS Biologiques Inc. develops novel products that address critical issues in aquatic, animal and human health sectors using innovative approaches and techniques. The company seeks to establish the commercial viability of advanced research projects and bring products to market through direct sales to customers, licensing fees and royalties from marketing partners.
Sona Nanotech is a gold nanorod platform technology company. They have developed the first line of biocompatible gold nanorods (GNRs) that are synthesized without the use of the conventionally used cytotoxic surfactant cetyltrimethylammonium bromide, commonly called CTAB. Sona is working with collaboration partners across Canada, the US and Europe to complete research data results and product prototyping, where their Sona Gemini™ and Omni™ brand gold nanorod products will be used as the enabling nanoparticle platform technology for projects ranging from cancer tumour destruction in humans and animals to targeted drug delivery, and new diagnostic test product platforms for infectious disease and women’s health.